PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis

PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis

IntroductionImmune checkpoint blockade (ICB) immunotherapy has revolutionized cancer treatment, demonstrating exceptional clinical responses in a wide range of cancers. Despite the success, a significant proportion of patients still fail to respond, highlighting the existence of unappreciated mechan...

Полное описание

Библиографические подробности
Главные авторы: Athina Boumpas, Antonis S. Papaioannou, Pavlos Bousounis, Maria Grigoriou, Veronica Bergo, Iosif Papafragkos, Athanasios Tasis, Michael Iskas, Louis Boon, Manousos Makridakis, Antonia Vlachou, Eleni Gavriilaki, Aikaterini Hatzioannou, Ioannis Mitroulis, Eirini Trompouki, Panayotis Verginis
Формат: Статья
Язык:English
Опубликовано: Frontiers Media S.A. 2024-10-01
Серии:Frontiers in Immunology
Предметы:
cancer
immunotherapy
bone marrow
hematopoietic stem and progenitor cell
inflammation
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1386838/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1386838/full

Схожие документы